What are the side effects of Ajovy (fremanezumab)?

Commonly reported side effects of Ajovy (fremanezumab) include: adrenaline surge, breathing issues lasting months, high blood pressure, hormonal side effects, increased migraines, injection pain, injection site color change, injection site pain, injection site rash, injection site scarring, injection site tenderness, migraine hangover for 12-24 hours, migraine triggered before injection, nausea, no improvement in migraine frequency, palpitations, panic attack, racing heart beat, severe allergic reaction near anaphylaxis, shaking, side effects became too much, site reactions, tolerance development after 7-9 months, unknown side effects, worsened migraines for about a week after injection, worsening of migraine symptoms. This treatment also carries an FDA black box warning.

How long does Ajovy (fremanezumab) take to work?

Ajovy (fremanezumab) typically shows results in 1–3 months, though individual responses vary.

Is Ajovy (fremanezumab) safe for long-term use?

Ajovy (fremanezumab) is considered safe for long-term use. Always consult your physician.

migraines Treatment Guide

Does Ajovy (fremanezumab) work for migraines?

Q: Does Ajovy (fremanezumab) work for migraines?

Research gives Ajovy (fremanezumab) a score of 75/100 for migraines (Strong), based on 19 studies. Real user reports score it 69/100.

Ajovy (fremanezumab) has a research efficacy score of 75/100 for migraines — rated Strong across 19 studies. Real users on social media rate it 69/100. It typically takes 1–3 months to show results.

Research

75 / 100

19 studies

Social

69 / 100

77 posts

Safety

64 / 100

See if Ajovy works for you — not just on average

Track daily, run your own experiment, get real data. Free.

Ajovy (fremanezumab) — treatment for migraines

How does Ajovy (fremanezumab) help migraines?

CGRP monoclonal antibody antagonism

Category: CGRP inhibitor

Efficacy: Research vs. Real Users

Research Evidence

75 / 100

Strong

19 studies · 5288 participants

Score derived from PubMed research published in the past year.

Real User Reports

69 / 100

Moderate

77 posts

Self-reported results can be biased. Use as context, not proof.

How It Works

Administration Injection, Every 30 days
Time to work 1–3 months
Adult dose target Adults with episodic or chronic migraines seeking preventive treatment, particularly those who have failed prior preventive therapies or have cardiovascular conditions precluding triptan use.
Child dose target Adolescents aged 12–17 with episodic or chronic migraines unresponsive to conventional preventive therapies, though further research is needed to establish optimal pediatric dosing.

Safety Profile

⚠ FDA Black Box Warning

This treatment carries an FDA black box warning — the most serious type of safety alert. Consult your doctor before use.

/ 100

Safety Score: Moderate

Higher scores indicate a more favorable safety profile.

Known Side Effects

adrenaline surge
breathing issues lasting months
high blood pressure
hormonal side effects
increased migraines
injection pain
injection site color change
injection site pain
injection site rash
injection site scarring
injection site tenderness
migraine hangover for 12-24 hours
migraine triggered before injection
nausea
no improvement in migraine frequency
palpitations
panic attack
racing heart beat
severe allergic reaction near anaphylaxis
shaking
side effects became too much
site reactions
tolerance development after 7-9 months
unknown side effects
worsened migraines for about a week after injection
worsening of migraine symptoms

Cautions

✓ Generally considered safe during pregnancy

✓ Considered safe for long-term use

Who Should Consider Ajovy (fremanezumab)?

Severity Mild, moderate, severe
Minimum age 12 years old
Effective areas head
Category Non-steroid Prescription Medication

Lemma Health

Download the app — free.

Track your own Ajovy experiment and see whether it's actually helping — backed by your own data.

Frequently Asked Questions

Does Ajovy (fremanezumab) work for migraines?: Research gives Ajovy a score of 75/100 for migraines (Strong), based on 19 studies. Real-user reports score it 69/100.
What are the side effects of Ajovy (fremanezumab)?: Commonly reported side effects include: adrenaline surge, breathing issues lasting months, high blood pressure, hormonal side effects, increased migraines, injection pain, injection site color change, injection site pain, injection site rash, injection site scarring, injection site tenderness, migraine hangover for 12-24 hours, migraine triggered before injection, nausea, no improvement in migraine frequency, palpitations, panic attack, racing heart beat, severe allergic reaction near anaphylaxis, shaking, side effects became too much, site reactions, tolerance development after 7-9 months, unknown side effects, worsened migraines for about a week after injection, worsening of migraine symptoms. This treatment also carries an FDA black box warning.
How long does Ajovy (fremanezumab) take to work?: Ajovy typically shows results in 1–3 months, though individual responses vary. Tracking your symptoms with a structured experiment can help you know sooner.
Is Ajovy (fremanezumab) safe for long-term use?: Ajovy is considered safe for long-term use. Always confirm with your physician.
How do you use Ajovy (fremanezumab)?: Ajovy is administered injection, Every 30 days, at a target dose of Adults with episodic or chronic migraines seeking preventive treatment, particularly those who have failed prior preventive therapies or have cardiovascular conditions precluding triptan use..
Is Ajovy (fremanezumab) safe during pregnancy or breastfeeding?: Ajovy is generally considered safe during pregnancy. Always confirm with your healthcare provider.

This page is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any treatment. Scores are derived from publicly available research and social media data and should not be used as a substitute for professional medical guidance.